Loomis, Sayles & Company
LFST icon

Loomis, Sayles & Company’s Lifestance Health LFST Stock Holding History

Loomis, Sayles & Company’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2M Buy
1,882,750
+200,419
+12% +$1.55M 0.03% 256
2026
Q1 		$10.7M Sell
1,682,331
-43,918
-3% -$306K 0.01% 344
2025
Q4 		$12.2M Sell
1,726,249
-259,821
-13% -$1.57M 0.01% 328
2025
Q3 		$10.9M Sell
1,986,070
-356,958
-15% -$1.75M 0.01% 346
2025
Q2 		$12.1M Buy
2,343,028
+100,657
+4% +$603K 0.02% 337
2025
Q1 		$14.9M Buy
+2,242,371
New +$17M 0.02% 284

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Loomis, Sayles & Company's LFST Position: Q2 2026 in Review

Loomis, Sayles & Company increased its Lifestance Health (LFST) stake by 12% in Q2 2026, buying an estimated $1.55M and bringing the position to 1,882,750 shares worth $20.2M. The position accounts for 0.03% of the portfolio, ranked #256.

Loomis, Sayles & Company first reported a position in LFST in Q1 2025 and has held it in 6 quarters since. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Loomis, Sayles & Company held 1,882,750 shares of Lifestance Health worth $20.2M as of Q2 2026.
  • Loomis, Sayles & Company bought 200,419 Lifestance Health shares in Q2 2026, an estimated $1.55M.
  • Lifestance Health made up 0.03% of Loomis, Sayles & Company's portfolio in Q2 2026, its #256 holding.
  • Loomis, Sayles & Company first reported a position in Lifestance Health in Q1 2025 and has held it in 6 quarters since.
  • 287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.